Literature DB >> 6146249

Patterns in drug utilization--national and international aspects: antihypertensive drugs.

I Baksaas.   

Abstract

There is a reasonable agreement between defined daily doses (DDDs) and prescribed daily doses (PDDs) of antihypertensive drugs, at least in Norway and Sweden. Sales and prescriptions of antihypertensive drugs in seven European countries (CSSR, Denmark, Finland, Iceland, Northern Ireland, Norway and Sweden) have increased 50 to 200% during the last 10 years. The drug statistics also illustrate marked qualitative and quantitative differences in the utilization of antihypertensive drugs between these seven European countries. Mortality in cardiovascular diseases also differs between these countries, particularly between Northern Ireland and Finland and the other countries. So do sales of alcohol and tobacco. However, none of these factors seem to co-vary with drug utilization.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146249     DOI: 10.1111/j.0954-6820.1984.tb08717.x

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


  12 in total

1.  Drug utilization in general practice: prescribing habits of National Formulary drugs by GPs of Emilia Romagna (Italy) in 1988 and 1989.

Authors:  N Montanaro; N Magrini; A Vaccheri; M Battilana
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Drug utilisation studies as tools in health economics.

Authors:  J A Sacristán; J Soto
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

Review 3.  Economic factors in the initiation of antihypertensive therapy.

Authors:  I Kawachi
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

Review 4.  Impact of drug usage review on drug utilisation.

Authors:  J L Blackburn
Journal:  Pharmacoeconomics       Date:  1993-01       Impact factor: 4.981

Review 5.  Differences in antidiabetic drug utilisation between three different health systems in the same national region.

Authors:  J Benítez; A M Puerto; J A Díaz
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  Utilization of benzodiazepines in Chile during 1982-1986.

Authors:  I Ruiz; J Offermanns; P Fuentes; M Castillo
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  Therapeutic auditing at the national and international level.

Authors:  B Westerholm
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

8.  Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden.

Authors:  K Griffiths; D G McDevitt; M Andrew; I Baksaas; P K Lunde; U Bergman; A Wessling; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Changing patterns of antihypertensive drug use in a German population between 1984 and 1987. Results of a population based cohort study in the Federal Republic of Germany.

Authors:  H W Hense; P Tennis
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

10.  Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes. WHO Drug Utilization Research Group (DURG).

Authors:  K Griffiths; D G McDevitt; M Andrew; I Baksaas; A Helgeland; J Jervell; P K Lunde; K Oydvin; I Agenäs; U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.